| |
| |
|
| Insider
Information: |
Francois Cedric |
| Relationship: |
Chief Executive Office... |
| City: |
Crestwood |
| State: |
KY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
313,662 |
|
|
Indirect Shares
|
1,721,568 |
|
|
| Direct
Value |
$13,409,051 |
|
|
|
Indirect Value
|
$73,597,032 |
|
|
| Total
Shares |
2,035,230 |
|
|
| Total
Value |
$87,006,083 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-5.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -168.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Apellis Pharmaceuticals Inc |
APLS |
Chief Executive Office... |
2024-03-01 |
313,662 |
2024-03-01 |
1,721,568 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
76 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2018-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
384,292 |
714,288 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
34,375 |
1,066,805 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2021-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
1,222,356 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2022-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
106,244 |
1,340,487 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2023-01-12 |
4 |
A |
$0.00 |
$0 |
D/D |
83,447 |
1,048,575 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• – – |
2023-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
13,908 |
1,046,193 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2024-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
72,094 |
341,749 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2019-08-15 |
4 |
AS |
$26.74 |
$268,007 |
D/D |
(10,000) |
989,288 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2019-09-16 |
4 |
AS |
$26.56 |
$132,949 |
D/D |
(5,000) |
1,021,793 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2019-10-15 |
4 |
AS |
$25.59 |
$131,551 |
D/D |
(5,000) |
1,016,793 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2019-11-15 |
4 |
AS |
$27.28 |
$136,405 |
D/D |
(5,000) |
1,011,793 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2019-12-16 |
4 |
AS |
$27.95 |
$139,750 |
D/D |
(5,000) |
1,006,793 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-01-15 |
4 |
AS |
$41.47 |
$1,500,787 |
D/D |
(35,638) |
1,001,793 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-02-18 |
4 |
AS |
$40.66 |
$1,449,122 |
D/D |
(35,637) |
1,027,430 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-03-16 |
4 |
AS |
$20.69 |
$759,934 |
D/D |
(35,637) |
1,053,067 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-04-15 |
4 |
AS |
$29.77 |
$148,850 |
D/D |
(5,000) |
1,113,079 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-05-15 |
4 |
AS |
$29.92 |
$149,600 |
D/D |
(5,000) |
1,108,079 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-06-15 |
4 |
AS |
$30.21 |
$151,050 |
D/D |
(5,000) |
1,103,079 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-07-15 |
4 |
AS |
$32.12 |
$160,600 |
D/D |
(5,000) |
1,098,079 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-08-18 |
4 |
AS |
$30.00 |
$46,290 |
D/D |
(1,543) |
1,096,536 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-08-20 |
4 |
AS |
$30.00 |
$103,710 |
D/D |
(3,457) |
1,093,079 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-09-15 |
4 |
AS |
$30.96 |
$154,800 |
D/D |
(5,000) |
1,088,079 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-10-15 |
4 |
AS |
$34.46 |
$172,300 |
D/D |
(5,000) |
1,083,079 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-11-16 |
4 |
AS |
$39.38 |
$196,900 |
D/D |
(5,000) |
1,078,079 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-12-15 |
4 |
AS |
$52.16 |
$260,800 |
D/D |
(5,000) |
1,113,079 |
0 |
% |
|
76 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
